ANIP
ANI Pharmaceuticals Inc
NASDAQ: ANIP · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$81.78
+0.91% today
Updated 2026-07-29
Market cap
$1.77B
P/E ratio
19.88
P/S ratio
1.91x
EPS (TTM)
$3.91
Dividend yield
—
52W range
$63 – $100
Volume
0.3M
ANI Pharmaceuticals Inc (ANIP) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$81.78
12-Month target
$61.55
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.3B | $0.5B | $0.6B | $0.9B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 19.88x (capped 25x) · Margin: 9.98%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.